Faces of BME – Amber Xue

PhD candidate from Molly Shoichet lab

My interest in biomedical sciences began at a young age as I grew up surrounded by physicians. I was inspired by my relatives who worked in different departments at hospitals. Driven by my strong desire to help others, I attended Harbin Medical University to become a medical doctor. During my undergraduate degree, I also trained in a pharmacological lab where I was responsible for testing a drug that was developed.

My research is focusing on a rare disease called lymphangioleiomyomatosis (LAM) that only impacts women of childbearing age. By investigating immune response to LAM cells in vitro, we analyzed the phenotype change of T cells and LAM cells over time. Additionally, by sequencing lung tissues from LAM patients and healthy people, we aim to target the transcriptome difference in LAM patients and further translate it into clinical.

I joined a non-profit organization named Podan Innovation Plan, which aims to transfer academic discoveries to industry by helping researchers and industrial actors to break the interdisciplinary barriers. The areas that I covered during my work for this organization range from CRISPR technology to AI diagnosis; from wearable medical devices to injectable materials; from single-cell analysis to blockchain application to medical science and marketing strategy. From the interactions with engineers, physicians, and researchers I have come to understand different perspectives and think more broadly.

Faces of BME is a series of biomedical engineering student profiles that focus on the student journey throughout graduate school, inside and outside the labs. We place emphasis on quotes and photos. If you are interested in being featured, please fill out the following form and we will get back to you as soon as possible.